Uh-oh! This study is no longer available.
Respiratory Syncytial Virus (RSV) Vaccine – Ages 60 – 80
Respiratory Syncytial Virus (RSV)
PMG Research of Hickory
A research study is evaluating an investigational vaccine for respiratory syncytial virus (RSV).
This research study may be an option if you:
• Have not previously been vaccinated for RSV
• Have no hypersensitivity to latex
• Have a Body Mass Index (BMI) below 40. Find out your BMI here http://bmicalculator.cc/
• Have no history of immunosuppressive disorders
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and study vaccine at no cost.
Patient Commitment Duration
Approximately 14 months
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 9 clinic visits